The up-regulation of inflammatory pathways during HMGA1-induced tumorigenesis is also consistent with our previous studies demonstrating that anti-inflammatory agents (sulindac and celecoxib) interfere with sarcomas in our HMGA1 transgenics [12]. This evidence concerns the gene HMGA1 and sarcoma.